Published in Gynecol Obstet Fertil on August 25, 2009
Complications after surgery for deeply infiltrating pelvic endometriosis. BJOG (2010) 2.79
Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol (2013) 2.33
[Prevention of port-site metastasis after laparoscopy]. Gynecol Obstet Fertil (2002) 2.06
[Results and fertility after conservative treatment of invasive epithelial ovarian cancer]. Gynecol Obstet Fertil (2002) 2.03
[Surgeons! Pity patients who suffer from endometriosis!]. Gynecol Obstet Fertil (2006) 2.03
[Surgical treatment for endometrial adenocarcinoma: first approaches. Review of the literature]. Gynecol Obstet Fertil (2003) 2.02
[Laparoscopic treatment of borderline ovarian tumor: analysis of 54 patients and clinical outcomes]. Gynecol Obstet Fertil (2005) 1.99
The learning curve of total laparoscopic hysterectomy: comparative analysis of 1647 cases. J Am Assoc Gynecol Laparosc (2002) 1.99
[Does endoscopic surgery have a role in radical surgery of cancer of the cervix uteri?]. J Gynecol Obstet Biol Reprod (Paris) (1990) 1.96
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer. Gynecol Oncol (2007) 1.83
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology (2011) 1.75
The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer (2000) 1.74
Management and clinical outcomes of pregnant patients with invasive cervical cancer. Ann Oncol (2005) 1.64
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients. Ann Surg Oncol (2012) 1.62
French recommendations on the management of invasive cervical cancer during pregnancy. Int J Gynecol Cancer (2009) 1.48
Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma. Radiother Oncol (2004) 1.46
[Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?]. Gynecol Obstet Fertil (2005) 1.44
Color Doppler energy prediction of malignancy in adnexal masses using logistic regression models. Ultrasound Obstet Gynecol (2002) 1.44
[Adnexal masses management: a prospective multicentric observational study]. Gynecol Obstet Fertil (2008) 1.42
[Pyosalpingitis after interadnexal laparoscopic hysterectomy. Two cases]. Gynecol Obstet Fertil (2005) 1.41
[Rubella in pregnancy. Management and prevention]. Presse Med (1999) 1.39
Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol (2010) 1.38
[Laparoscopic treatment of endometriomas: cystectomy or destruction? For laparoscopic cystectomy]. Gynecol Obstet Fertil (2000) 1.38
Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.37
[Modalities and limits of conservative treatment of adenocarcinoma in situ of the uterine cervix: analysis of nine cases and review of the literature]. Gynecol Obstet Fertil (2003) 1.37
Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer (2000) 1.35
Laparoscopic management of adnexal torsion. A review of 35 cases. J Reprod Med (1989) 1.27
Total laparoscopic hysterectomy for very enlarged uteri. J Am Assoc Gynecol Laparosc (2002) 1.26
Does prevention of intraperitoneal spillage when removing a dermoid cyst prevent granulomatous peritonitis? BJOG (2010) 1.24
Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients. Cancer (1996) 1.23
The role of laparoscopy in the diagnosis and management of heterotopic pregnancies. Hum Reprod (1997) 1.22
External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours. Br J Cancer (2013) 1.17
Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol (2012) 1.14
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res (1992) 1.13
Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study. Cancer (2001) 1.12
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results. J Clin Oncol (1997) 1.12
Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol (2003) 1.10
Prediction of pregnancy in infertile women based on the American Society for Reproductive Medicine's revised classification of endometriosis. Fertil Steril (1997) 1.09
Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study. Acta Otolaryngol (2007) 1.07
Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil Steril (2001) 1.07
Conservative laparoscopic treatment of 321 ectopic pregnancies. Fertil Steril (1986) 1.05
Laparoscopic salpingostomy: fertility results according to the tubal mucosal appearance. Hum Reprod (1994) 1.04
Adult granulosa-cell tumor of the ovary: a retrospective study of 45 cases. Int J Gynecol Cancer (1997) 1.03
Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol (1996) 1.02
Prognosis of stage III or IV primary peritoneal serous papillary carcinoma. Eur J Surg Oncol (2004) 1.01
Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol (1998) 1.01
Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis? Ultrasound Obstet Gynecol (2006) 0.99
Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol (2009) 0.99
Salpingectomy - the laparoscopic surgical choice for ectopic pregnancy. Hum Reprod (1996) 0.99
Patient dose reference levels for interventional radiology: a national approach. Cardiovasc Intervent Radiol (2008) 0.98
Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study. Ann Oncol (2003) 0.98
Sterilization reversal: fertility results. Hum Reprod (1995) 0.97
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 0.97
CO2 laser laparoscopy. Baillieres Clin Obstet Gynaecol (1989) 0.97
Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab (2000) 0.96
Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocations in chronic myelocytic leukemia. Cancer Genet Cytogenet (2003) 0.93
Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type. Ann Oncol (2007) 0.93
Malignant degeneration of perineal endometriosis in episiotomy scar, case report and review of the literature. Int J Gynecol Cancer (2007) 0.93
Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma. Ann Oncol (2002) 0.93
Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population. Mol Hum Reprod (1997) 0.92
Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol Hum Reprod (1999) 0.92
[Laparoscopic treatment of ovarian cysts. Indications, techniques, results. Apropos of 650 cases]. Chirurgie (1991) 0.92
Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients. Eur J Gynaecol Oncol (2003) 0.92
Uterine rupture during pregnancy after laparoscopic myomectomy. Hum Reprod (1995) 0.92
[Laparoscopy during pregnancy: experience of the French university hospital of Clermont-Ferrand]. Gynecol Obstet Fertil (2009) 0.92
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Leukemia (2003) 0.91
Results of conservative treatment in epithelial ovarian carcinoma. Cancer (2001) 0.91
Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study. Eur J Surg Oncol (2010) 0.91
Borderline ovarian tumors diagnosed during pregnancy exhibit a high incidence of aggressive features: results of a French multicenter study. Ann Oncol (2011) 0.90
[Laparoscopic management of ovarian cysts during pregnancy]. Gynecol Obstet Fertil (2006) 0.90
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol (2008) 0.90
DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. Mol Hum Reprod (2004) 0.90
Treatment of ovarian dermoid cysts. Place and modalities of operative laparoscopy. Surg Endosc (1994) 0.90
Morbidity in laparoscopic gynecological surgery: results of a prospective single-center study. Surg Endosc (1999) 0.90
Feasibility of ovarian cryopreservation in borderline ovarian tumours. Hum Reprod (2008) 0.89
Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma. Ann Oncol (2010) 0.89
[External validation of simple ultrasound rules of Timmerman on 122 ovarian tumors]. Gynecol Obstet Fertil (2011) 0.88
Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary. Ann Oncol (2013) 0.88
Gestational choriocarcinoma transmission following multiorgan donation. Am J Transplant (2010) 0.88
Fibrogenesis in peritoneal endometriosis. A semi-quantitative analysis of type-I collagen. Gynecol Obstet Invest (1999) 0.87
Promontofixation for the treatment of prolapse. Urol Clin North Am (2001) 0.86
Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature. Clin Oncol (R Coll Radiol) (2000) 0.86
Human endometriosis-derived permanent cell line (FbEM-1): establishment and characterization. Hum Reprod Update (1997) 0.86
Peritoneal closure reduces port site metastases: results of an experiment in a rat ovarian cancer model. Surg Endosc (2001) 0.86
Bladder injuries during total laparoscopic hysterectomy: diagnosis, management, and prevention. J Gynecol Surg (1995) 0.86
Extradural clonidine combined with sufentanil and 0.0625% bupivacaine for analgesia in labour. Br J Anaesth (1996) 0.86
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma. Ann Surg Oncol (2011) 0.86
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol (2001) 0.85
Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias. Ann Oncol (2010) 0.85
Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas. Gynecol Oncol (2001) 0.85